NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for cancer patients, particularly those who do not respond to existing treatments or whose cancer progresses despite therapy. The company utilizes differentiated mechanisms of action and antibody-drug conjugates to create tumor-specific therapies aimed at addressing the complexities of the tumor microenvironment and immune evasion. NextCure targets patients with cancer types that are not adequately treated by current therapies.